JESSICA PACK: Open Payments
NPI 1629609359 · LYNCHBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,412 in 15 payments from 13 companies in 2025. Trend: 2023 $487 · 2024 $642 · 2025 $1,412
Food & beverage: $1,412
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 3 | $331 |
| Lundbeck LLC | 1 | $121 |
| Novo Nordisk Inc | 1 | $113 |
| Phathom Pharmaceuticals, Inc. | 1 | $113 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $111 |
| Merck Sharp & Dohme LLC | 1 | $110 |
| Amgen Inc. | 1 | $109 |
| ABBVIE INC. | 1 | $88 |
| ARGENX US, INC. | 1 | $88 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $87 |
Products named: Dexcom G6 Transmitter, VYEPTI, Ozempic, VOQUEZNA, CAPLYTA, CAPVAXIVE, EVENITY, QULIPTA.
Industry payments across VA — which companies pay providers there.
